DEF 14A

Company

AIM ImmunoTech Inc.

Filed

May 12, 2005

Period of Report

June 22, 2005

Accession Number

0000891092-05-000927

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →